UK approves Pfizer jab for 12 to 15-year-olds

By | June 4, 2021

The data is based on more than 2,000 children aged 12-15 years old who took part in trials of the Pfizer vaccine. There were no cases of Covid from a week after the second dose – compared to 16 cases in the placebo group, and the vaccine appeared to work as well in adolescents as in young adults aged 16-25.

BBC News – Health

Read More:  FDA Approves Bylvay (odevixibat) for the Treatment of Pruritus in Patients with Progressive Familial Intrahepatic Cholestasis (PFIC)